Cormedix Inc (CRMD)
5.17
-0.24
(-4.44%)
USD |
NASDAQ |
May 10, 16:00
5.165
0.00 (0.00%)
After-Hours: 20:00
Cormedix Price: 5.17 for May 10, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
May 10, 2024 | 5.40 | 5.510 | 5.075 | 5.17 | 991703.0 |
May 09, 2024 | 5.85 | 5.89 | 5.36 | 5.41 | 896049.0 |
May 08, 2024 | 5.82 | 5.97 | 5.62 | 5.705 | 810912.0 |
May 07, 2024 | 5.85 | 5.95 | 5.80 | 5.84 | 466594.0 |
May 06, 2024 | 5.95 | 6.075 | 5.83 | 5.89 | 748677.0 |
May 03, 2024 | 5.49 | 5.92 | 5.430 | 5.84 | 1.029M |
May 02, 2024 | 5.53 | 5.588 | 5.280 | 5.37 | 625572.0 |
May 01, 2024 | 5.24 | 5.70 | 5.23 | 5.52 | 902216.0 |
Apr 30, 2024 | 5.25 | 5.335 | 5.18 | 5.255 | 373158.0 |
Apr 29, 2024 | 5.32 | 5.39 | 5.18 | 5.28 | 365723.0 |
Apr 26, 2024 | 5.18 | 5.33 | 5.09 | 5.31 | 315424.0 |
Apr 25, 2024 | 5.25 | 5.41 | 5.11 | 5.19 | 745281.0 |
Apr 24, 2024 | 5.48 | 5.49 | 5.275 | 5.33 | 422944.0 |
Apr 23, 2024 | 5.29 | 5.579 | 5.26 | 5.45 | 572806.0 |
Apr 22, 2024 | 5.25 | 5.30 | 5.00 | 5.28 | 465594.0 |
Apr 19, 2024 | 5.50 | 6.22 | 5.13 | 5.28 | 1.992M |
Apr 18, 2024 | 5.45 | 5.765 | 5.33 | 5.42 | 628596.0 |
Apr 17, 2024 | 5.47 | 5.56 | 5.29 | 5.44 | 731947.0 |
Apr 16, 2024 | 5.44 | 5.51 | 5.12 | 5.41 | 719967.0 |
Apr 15, 2024 | 5.98 | 6.17 | 5.155 | 5.38 | 1.502M |
Apr 12, 2024 | 6.44 | 7.00 | 5.735 | 5.84 | 2.328M |
Apr 11, 2024 | 5.41 | 6.40 | 5.25 | 6.39 | 2.636M |
Apr 10, 2024 | 4.67 | 5.34 | 4.65 | 5.28 | 1.505M |
Apr 09, 2024 | 4.85 | 4.875 | 4.68 | 4.75 | 438540.0 |
Apr 08, 2024 | 4.74 | 4.88 | 4.65 | 4.76 | 642629.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
2.35
Minimum
Mar 18 2020
17.58
Maximum
Feb 19 2021
5.403
Average
4.89
Median
Oct 21 2021
Price Benchmarks
BioXcel Therapeutics Inc | 2.09 |
ACADIA Pharmaceuticals Inc | 15.25 |
Cassava Sciences Inc | 20.23 |
Vertex Pharmaceuticals Inc | 422.78 |
Oragenics Inc | 1.84 |
Price Related Metrics
PS Ratio | 4020.78 |
Price to Book Value | 4.052 |
Earnings Yield | -17.80% |
Market Cap | 284.25M |